Using a co-culture model of CRC organoids and T cells, researchers screened a series of small molecule inhibitors and found that DKK1 inhibitors could significantly enhance the killing effect of T cells and promote apoptosis of tumor cells by regulating the GSK3ß-E2F1-T-bet axis in CD8+ T cells. Here, CD8A is linked to neoplasm.